{
    "2021-07-08": [
        [
            {
                "time": "",
                "orginal_text": "鼓励挑战专利，支持首仿！正大天晴、东阳光、恒瑞、齐鲁、人福等头部企业百舸争流",
                "features": {
                    "keywords": [
                        "首仿",
                        "正大天晴",
                        "东阳光",
                        "恒瑞",
                        "齐鲁",
                        "人福",
                        "头部企业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "抗癌药百泽安第八项适应症受理 PD-1竞速下创新药巨头离盈利还有多远？",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "百泽安",
                        "PD-1",
                        "适应症",
                        "创新药",
                        "盈利"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "遭遇集采“闷棍”，恒瑞进军冷门品种",
                "features": {
                    "keywords": [
                        "集采",
                        "恒瑞",
                        "冷门品种"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "集采常态化加速行业洗牌 药企抢占新药与非医保赛道",
                "features": {
                    "keywords": [
                        "集采",
                        "常态化",
                        "行业洗牌",
                        "新药",
                        "非医保"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-07-07",
                "orginal_text": "A股融资融券日报：两融余额增加101.08亿元（7月7日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "A股",
                        "融资融券"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药创新长期高景气，看多龙头公司",
                "features": {
                    "keywords": [
                        "医药创新",
                        "高景气",
                        "龙头公司"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "集采常态化加速行业洗牌，药企转型抢占新药与非医保赛道",
                "features": {
                    "keywords": [
                        "集采",
                        "常态化",
                        "行业洗牌",
                        "转型",
                        "新药",
                        "非医保"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}